Chemed Corporation

CHE Healthcare Medical Care Facilities

Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.

Revenue
+10.6%
EPS
+23.1%
Free cash flow
−45.3%

Quarter to September 2026, against a year earlier

533.55 15.09 −2.75%
Market cap
$7.0B
P/E
25.5×
Fwd P/E
24.0×
Dividend yield
0.47%
F-score
6/9
Altman Z
11.69
Beneish M
−2.76
Dividend safety
100/100

Chemed Corporation (CHE) Debt to equity

Alert me on Debt to equity

Chemed Corporation's debt to equity at the end of the quarter to 30 September 2026 was 0.3×, up 0.3× from fiscal 2025 (0.0×). Over the past ten years it has ranged from 0.0× (fiscal 2025) to 0.4× (fiscal 2021) — the current reading is the lowest in ten years. That is below the Medical Care Facilities industry median of 0.4× and above the Healthcare sector median of 0.0×.

Debt to equity, annual

Embed this chart

Annual newest first

Period Debt to equity Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.1× (67.61%)
FY2021 0.4× 151.67%
FY2020 0.1× (21.69%)
FY2019 0.2× 9.63%
FY2018 0.2× (6.83%)
FY2017 0.2× (9.73%)
FY2016 0.2× 16.70%

Quarterly newest first

Period Debt to equity Change
Sep 2026 0.3× 62.51%
Jun 2026 0.2× 56.84%
Mar 2026 0.1× —
Dec 2025 0.0× —
43 more quarters

Against its own ten years

Low 0.0× High 0.4×
Ten-year median 0.2×
Current reading's percentile 27

Debt to equity against peers

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on CHE